{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181797.3:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_181797.3",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant"
        },
        {
          "HGVS": "NM_181797.3:c.4321C>T",
          "cDNA Change": {
            "transcript": "NM_181797.3",
            "ref": "C",
            "alt": "T",
            "position": "4321"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005313"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing LRRK2 variants",
        "Description": "HEK293 cells were transfected with plasmids encoding wild-type or mutant LRRK2 proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181797.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S variant showed a 2.5-fold increase in kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_181797.3:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "R1441C variant exhibited 40% reduced kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity deviating by >30% from wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Parkinson's disease patients",
        "Description": "Brain tissue samples were collected from patients with confirmed Parkinson's disease and healthy controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_181797.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S variant showed increased phosphorylation of substrates in patient-derived tissues."
        },
        {
          "Variant": "NM_181797.3:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "R1441C variant exhibited reduced phosphorylation in patient-derived tissues."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five independent brain tissue samples were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each tissue sample was stained in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type brain tissue from healthy controls was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific antibody staining was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used for categorical data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 15% of control tissue.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels deviating by >35% from control tissue.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}